María José C. C.
- Country
- Spain
- Department
- Servicio de Infecciosas
Research Overview
- Evaluation of Efficacy, Safety, and Tolerability of Switching from Bictegravir/Emtricitabine/Tenofovir Alafenamide to Dolutegravir/Lamivudine in Virologically Suppressed HIV Patients Aged 50+
- Evaluation of Safety and Efficacy in Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV Patients with Neuropsychiatric Vulnerabilities
- A Randomized Open-Label Trial Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for Maintenance of Virological Suppression in HIV
Data & Insights
Has run more than one trial at 37 of 99 partner sites.
Specializations
HIV Treatment Innovation
The investigator specializes in antiretroviral therapy optimization for individuals living with HIV, with particular emphasis on evaluating treatment switches and maintenance strategies.
- Treatment-experienced patient care
- Viral suppression maintenance
- Long-acting therapeutic solutions
Their research extends to examining novel fixed-dose combinations and their impact on virologic control.
Special Population Focus
The investigator demonstrates particular interest in targeted HIV treatment approaches for specific patient populations, including older adults and individuals with neuropsychiatric considerations.
- Older adult HIV management
- Neuropsychiatric vulnerabilities
- Treatment optimization strategies
Their work encompasses evaluating treatment appropriateness and safety in diverse patient groups.
Treatment Comparison Studies
The investigator conducts comparative effectiveness research examining various antiretroviral treatment regimens, focusing on both established and emerging therapeutic options.
- Drug combination efficacy
- Treatment switching outcomes
- Long-term effectiveness evaluation
Their research includes assessment of both oral and long-acting therapeutic alternatives.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.